Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio includes radiological products including an array of x-ray imaging agents and the MRT imaging agent; and veterinary pharmaceuticals. It also offers synthesis of active pharmaceutical substances (APIs), drug formulation and pharmaceutical production and contract research. Apart from Austria, Sanochemia offers its products in Remaining Europe, Asia, MENA (Middle East and North Africa), Commonwealth of Independent States (CIS) countries and rest of the world. The company has sales offices in Switzerland, Germany, the UK and the US. Sanochemia is headquartered in Vienna, Austria.
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.